SJOGREN'S SYNDROME
Clinical trials for SJOGREN'S SYNDROME explained in plain language.
Never miss a new study
Get alerted when new SJOGREN'S SYNDROME trials appear
Sign up with your email to follow new studies for SJOGREN'S SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could CAR-T cells tame autoimmune diseases? new trial launches
Disease control TerminatedThis early-stage study tests a new treatment called RD06-04, which uses a patient's own immune cells modified to target and destroy faulty immune cells causing disease. It involves 12 adults with active autoimmune conditions like lupus or scleroderma. The main goal is to check sa…
Matched conditions: SJOGREN'S SYNDROME
Phase: EARLY_PHASE1 • Sponsor: Nanjing Bioheng Biotech Co., Ltd. • Aim: Disease control
Last updated May 07, 2026 18:39 UTC
-
New Sjögren's drug shows promise in Mid-Stage trial
Disease control OngoingThis study tests an experimental drug called HZN-1116 in 209 adults with Sjögren's syndrome, an autoimmune disease that causes dry eyes and mouth. Participants receive either the drug or a placebo to see if it reduces disease activity and improves symptoms like pain. The goal is …
Matched conditions: SJOGREN'S SYNDROME
Phase: PHASE2 • Sponsor: Amgen • Aim: Disease control
Last updated May 07, 2026 18:39 UTC
-
New hope for Sjogren's: oral drug tofacitinib under safety review
Disease control OngoingThis early-phase trial evaluated the safety of tofacitinib, an oral drug that targets inflammation, in 23 adults with mild-to-moderate Sjogren's syndrome. Participants took the drug or a placebo for 168 days and were monitored for side effects. The goal was to see if tofacitinib …
Matched conditions: SJOGREN'S SYNDROME
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) • Aim: Disease control
Last updated May 06, 2026 16:15 UTC
-
Shingles vaccine shows promise for High-Risk rheumatic patients
Prevention OngoingThis study looks at how safe and effective the Shingrix vaccine is for people with autoimmune rheumatic diseases like rheumatoid arthritis and lupus, who have a higher risk of shingles. About 2,000 participants will receive the vaccine or a placebo, and researchers will monitor d…
Matched conditions: SJOGREN'S SYNDROME
Phase: PHASE4 • Sponsor: University of Sao Paulo General Hospital • Aim: Prevention
Last updated May 07, 2026 18:42 UTC
-
Arthritis study tackles Life's hurdles to keep patients in care
Knowledge-focused OngoingThis study looks at how social factors like housing, food, or transportation affect whether people with inflammatory arthritis miss their doctor visits. About 100 adults with arthritis who have missed appointments in the past year will be randomly assigned to receive a list of co…
Matched conditions: SJOGREN'S SYNDROME
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated May 06, 2026 16:15 UTC